$AKCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AKCEA THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AKCEA THERAPEUTICS, INC.. Get notifications about new insider transactions in AKCEA THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.14 | 18,386 | 590,856 | 0 | 18.4 K to 0 (-100.00 %) |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 18,386 | 119,141 | 18,386 | 0 to 18.4 K |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | A | 30.73 | 150,000 | 4,609,500 | 150,000 | |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | J | 21.51 | 493 | 10,606 | 2,880 | 2.4 K to 2.9 K (+20.65 %) |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | A | 30.73 | 296,000 | 9,096,080 | 296,000 | |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Boyce Sarah | President | Option Exercise | A | 30.73 | 173,000 | 5,316,290 | 173,000 | |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | O'Dea Louis | Chief Medical Offic ... | Option Exercise | A | 30.73 | 83,000 | 2,550,590 | 83,000 | |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 30.73 | 83,000 | 2,550,590 | 83,000 | |
| Oct 18 2018 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,671,849 | 0 | 67,383,965 | 65.7 M to 67.4 M (+2.54 %) |
| Oct 18 2018 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,671,849 | 0 | 67,383,965 | 65.7 M to 67.4 M (+2.54 %) |
| Aug 06 2018 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,597,571 | 0 | 65,712,116 | 64.1 M to 65.7 M (+2.49 %) |
| Jul 02 2018 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | J | 14.77 | 1,398 | 20,653 | 2,387 | 989 to 2.4 K (+141.35 %) |
| Jul 02 2018 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | J | 14.77 | 1,398 | 20,653 | 2,387 | 989 to 2.4 K (+141.35 %) |
| Jun 28 2018 | AKCA | AKCEA THERAPEUTICS ... | GABRIELI CHRISTOPHER | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | PARSHALL B LYNNE | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | FITZGERALD EDWARD M | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | MOSCICKI RICHARD A | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | MOSCICKI RICHARD A | Director | Option Exercise | A | 23.46 | 53,000 | 1,243,380 | 53,000 | |
| May 08 2018 | AKCA | AKCEA THERAPEUTICS ... | PARSHALL B LYNNE | Director | Option Exercise | A | 21.67 | 53,000 | 1,148,510 | 53,000 | |
| Apr 19 2018 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 18.75 | 10,666,666 | 199,999,988 | 64,114,545 | 53.4 M to 64.1 M (+19.96 %) |
| Apr 19 2018 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 8,000,000 | 0 | 53,447,879 | 45.4 M to 53.4 M (+17.60 %) |
| Apr 18 2018 | AKCA | AKCEA THERAPEUTICS ... | Boyce Sarah | President | Option Exercise | A | 23.93 | 1,000,000 | 23,930,000 | 1,000,000 | |
| Apr 18 2018 | AKCA | AKCEA THERAPEUTICS ... | Boyce Sarah | President | Grant | A | 0.00 | 20,894 | 0 | 20,894 | 0 to 20.9 K |
| Apr 17 2018 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | A | 23.93 | 320,000 | 7,657,600 | 320,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | President & CEO | Option Exercise | A | 17.38 | 275,000 | 4,779,500 | 275,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | A | 17.38 | 110,000 | 1,911,800 | 110,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | J | 6.80 | 989 | 6,725 | 989 | 0 to 989 |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | O'Dea Louis | Chief Medical Offic ... | Option Exercise | A | 17.38 | 120,000 | 2,085,600 | 120,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 17.38 | 30,000 | 521,400 | 30,000 | |
| Sep 05 2017 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 18.65 | 332,708 | 6,205,004 | 332,708 | |
| Jul 21 2017 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 28,884,540 | 0 | 0 | |
| Jul 21 2017 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 8.00 | 3,125,000 | 25,000,000 | 45,447,879 | 42.3 M to 45.4 M (+7.38 %) |
| Jul 21 2017 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 13,438,339 | 0 | 42,322,879 | 28.9 M to 42.3 M (+46.52 %) |
| Jul 21 2017 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 28,884,540 | 0 | 28,884,540 | 0 to 28.9 M |